SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Kyntra Bio, Inc. (KYNB) on Monday reported a loss of $14.2 million in its fourth quarter.

The San Francisco-based company said it had a loss of $3.51 per share. Losses, adjusted to account for discontinued operations, were $3.61 per share.

The biotech drug developer posted revenue of $1.3 million in the period.

For the year, the company reported profit of $183.5 million, or $45.37 per share. Revenue was reported as $6.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KYNB at https://www.zacks.com/ap/KYNB